Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Re: Schrock & RIMM are obviously great news for us...

If the next 10Q is "light" to our line of thinking and the number of known licensees, would you think that it is reasonable to infer that we are receiving on-going license revenue (as I can't invision the price tag going down).

Is it at all possible that they are forced to report the numbers (due to some FASB rule, SEC, or other) such that they account for revenue on a straingt line basis even if they receive such monies in a lump sum?

Is it also possible that they are receiving a hodge podge of monies (some on-going and some lump sum) such that they are not required to report a change / switch to on-going payments..since some are and some are not..

just a few thoughts..pehaps some accountants here can chime in..

2
Apr 22, 2008 10:33AM
Share
New Message
Please login to post a reply